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atives were observed in a test of 45 positive and 45 negative samples. The acoustic prion sensor was constructed
using a thickness shear mode quartz resonator coated with a covalently bound recombinant prion protein. The
characteristic indicator of a scrapie infected sheep brain sample was an observed shoulder in the frequency de-
crease in response to a sample.
The response of the sensor aligns with a conformational shift in the surface protein and with the propagation
mechanism of the disease. This alignment is evident in the response timing and shape, dependence on concen-
tration, cross species behaviour and impact of blood plasma. This alignment is far from sufﬁcient to prove the
mechanism of the sensor but it does offer the possibility of a rapid and inexpensive additional tool to explore
prion disease.
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Prions, the infectious pathogens that cause transmissible spongiform
encephalopathies in animals, are proteins containing no genetic materi-
al. The normal or healthy form of the cellular prion protein (PrPC) is
found in mammalian tissue. The pathogenic form (PrPSc), found in dis-
eased tissue, differs from the normal protein form only in the protein's
conformation or shape [1]. Although the designation PrPSc is named
for scrapie, the disease in sheep, it is used to designate any infectious
prion protein. PrPC and PrPSc have the same amino acid sequence. Pan
et al. [2] determined the secondary structures of both PrPC and PrPSc.
PrPC has 42% of its peptides folded in anα-helix conﬁgurationwith little
(3%) in the β-sheet form, while PrPSc has 30% in the α-helix form and
43% in the β-sheet form. The change to the β-sheet form appears to
make the protein insoluble in detergent media and confers resistance
to digestion by protease enzymes. A resistant fragment, consisting of
50% in the β-sheet form, retains its infective capacity [3].
The conversion of PrPC to PrPSc occurs in vivo as PrPSc acts as a tem-
plate, binding and refolding PrPC [1]. Other co-factors such as chaperone
proteins may be involved. The conversion has also been carried out in
vitro [4]. Here, PrPSc was incubated with uninfected brain homogenate
which provided PrPC as well as possible unidentiﬁed co-factors. The
PrPC appeared to bind to the PrPSc, which should it be prompted to re-
fold, would increase the size of the initially introduced PrPSc oligomers.
The present work presents the proof of principle for an acoustic
assay technique using a thickness shearmode sensor (TSM). The prima-
ry objective of this paper is to demonstrate the capacity to distinguish.
. This is an open access article underscrapie positive (clinically infected) and negative sheep brain samples.
The premise of the technique in thiswork is that the TSM surface, coated
with a recombinant sheep PrPC, will bind sample proteins, which may
lead to conformational shifts on the surface. A secondary objective of
the paper is to explore whether the TSM response is consistent with
this premise. If this is valid, the TSM techniquemay offer further insight
into the disease.
To achieve the primary objective, two criteriamust be satisﬁed. First,
the response to positive test samples must be a reproducible resonant
frequency and/or energy dissipation signal that is signiﬁcantly higher
than the background ﬂuctuation of these signals, and second, the re-
sponse to positive test samples must be distinguishable from the re-
sponse to negative samples.
The secondary objective builds on the operating principles of TSMs.
The TSM is a piezoelectric crystalwafer that oscillates through the entire
crystal with motion parallel to the crystal faces and resonates at a fre-
quency primarily determined by the thickness of the crystal. There are
several mechanisms that shift the resonant frequency of a TSM device
[5]. The ﬁrst is a mass response ﬁrst quantiﬁed by Sauerbrey [6]. A
mass rigidly attached to the crystal surface stores kinetic energy, reduc-
ing the velocity and hence the frequency required to match the kinetic
energy to the elastic energy stored in the shear deformation of the crys-
tal. This match is required for resonance.
The secondmechanism is the interaction between the crystal surface
and a surrounding ﬂuid medium. Kinetic energy is transferred to the
ﬂuid, but unlike rigidly attached mass, only some of the energy is
returned to the crystal. Kanazawa and Gordon [7] showed that the vis-
cous energy is lost as a shearwavepropagates into the liquid but the vis-
cous effect is conﬁned to within a few hundred nanometers from the
crystal surface. Again the resonant frequency is reduced and the energythe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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electrically.
The third mechanism, which provides the basis for this acoustic
prion assay, involves the coupling between the crystal surface and the
ﬂuid [5]. Thematch between the polarity of the ﬂuid and the hydropho-
bicity of the surface determines the strength of the kinetic energy cou-
pling between the two. The weaker the coupling, the less the ﬂuid
viscosity will reduce the resonant frequency of the crystal.
Following the premise outlined above, we hypothesize that the
overall response of this TSM sensor conﬁguration, when exposed to a
positive sample, is a combination of three mechanisms. Ideally, the
PrPSc in positive samples would trigger a change in the recombinant
prion protein coating the TSM sensor, resulting in a more hydrophobic
surface as α-helices convert to β-sheets, leading to a change in surface
hydrophobicity and a measurable resonant frequency shift. This would
occur with a background frequency reduction as other proteins and
cell debris bind to the coated surface.
2. Materials and methods
The TSM sensors used in this assay were made with 9 MHz AT-cut
quartz crystals manufactured by Laptech Precision Inc. (Bowmanville,
Ontario). The 13.5 mm diameter crystals were glued to replace the bot-
toms of 11 mm glass vials using food grade RTV-108 silicone cement
(MG Chemicals, Surrey, BC). The vial with an attached crystal is shown
in Fig. 1. The gold electrodes, deposited onto both ﬂat surfaces of the
crystal, were 5 mm in diameter. This diameter allowed sufﬁcient clear-
ance from the glue joint to prevent any observable interferencewith the
crystal oscillations. Choosing a larger crystal diameter relative to the
glass vial provided a ﬂange for clamping the sensor into a test ﬁxture.
The gold electrodeswere connected via the test ﬁxture, to an oscilla-
tor, a PLO-10i (Inﬁcon, East Syracuse, NY) which phase locked the out-
put to the series resonant frequency of the crystal. The frequency and
motional resistance were continuously measured and 10 s averages
were recorded using a custom-built frequency counter and analog con-
version system.
The preparation of the crystal surfaces required linking, activating
and coating procedures which were adapted from Lyle et al. [8]. TheFig. 1. Test vial with attached crystal.linking reagents were obtained from Sigma-Aldrich (St. Louis, MO)
and used as received. The linking procedure required that inside sur-
faces of test vials were cleanedwith the following sequence of reagents:
10% nitric acid, water, acetone and ethanol. Under a nitrogen atmo-
sphere the gold surfaces inside the test vials were coated with 11-
mercapto undecanoic acid (11-MUA) by soaking in a 10 mM solution
of 11-MUA in ethanol at room temperature. After 24 h, this solution
was removed, the vials washed with ethanol, dried with nitrogen and
capped. The vials were then refrigerated until used.
At the time of each trial, one vialwas opened, installed in the test ﬁx-
ture and connected to the oscillator. The activating step involved adding
350 μL of 15 mM N-hydroxy succinimide (NHS) in water to 350 μL of
75 mM 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochlo-
ride (EDC) in water, mixed at room temperature and then placed in
the vial for 1 h at 37 °C. The activator solution was then removed and
the vial was washed with water. This left succinimidyl ester groups on
the 11-MUA linker.
The coating step involved adding 200 μL of a recombinant sheep PrPC
solution to the vial for 1 h at 37 °C. The PrPC coating solution was pre-
pared by adding 1 mL of 10 mM acetate buffer at pH 4.0 to 100 μg of
the recombinant protein as supplied by the manufacturer (AJ
Roboscreen GmbH, Leipzig). Exposed NH2 groups on the recombinant
protein formed amide bonds with the bound succinimide ester. After
the 1 h coating step, the vial was washed with acetate buffer. Buffered
homogenate was then mixed as described below, added to the vial
and frequency and resistance data were collected with the vial incubat-
ed at 37 °C.
Brain sample homogenates were generated by identical methods for
both positive and negative samples. Scrapie positive samples were
taken from sheep showing clinical signs of the disease and the infection
was conﬁrmed by both ELISA and immuno-histochemical examination
[9]. In summary, 1 g of fresh brain tissue was cut into three portions.
Each portion was separately weighed (350 mg ± 40 mg) and added
to a BioRad grinding tube together with 1.75 mL of 5% glucose solution
and a “1/4” ceramic bead. A Fast-Prep Ribolyzer ground the mixture
using one 45 s agitation cycle. The three portionswere then recombined
and mixed thoroughly. The combined homogenate was divided into
300 μL aliquots and stored at−70 °C until use.
Each brain sample was prepared from the frozen homogenate.
175 μL of this brain homogenate was thawed at 4 °C for 2–3 h, and
added to 125 μL of buffer [4] containing 0.5% Triton X-100 and 0.05% so-
dium dodecyl sulphate in phosphate buffered saline at pH 7.4. 50 μL of
COMPLETE™ protease inhibitor (Roche Diagnostics GmbH, Germany)
was also added at this step to block any protease enzymes present in
the brain samples.
3. Results and discussion
3.1. Proof of principle
Fig. 2 provides the raw frequency shifts for three normal and three
scrapie infected brain samples. The large pulses (at the zero, one and
2 h marks) are artifacts occurring when the ﬂuid in the crystal vial
was replaced. Over the ﬁrst hour, the crystal surface was activated
with the EDC/NHS linker. Over the second hour the surface was coated
with the recombinant PrPC. At the 2 h mark, the recombinant protein
coating solution was removed, the brain sample was added and the
data recorded for several hours. The frequency shifts for all samples
have been normalized to a zero based on the frequency obtained with
the recombinant PrPC solution (between 1 and 2 h).
There are two evident differences between the normal and scrapie
sample responses. The ﬁrst is the overall magnitude of the frequency
shift and the second is the different shape of the response curves. The
scrapie samples lead to a noticeable shoulder in the response curves.
The presence of this shoulder is the key distinguishing response of the
TSM.
Fig. 2. Example frequency response for three scrapie negative and three scrapie positive
sheep brain samples tested using the acoustic prion assay.
Fig. 4. Peaks resulting from the extraction of the frequency shoulder from data generated
by the acoustic prion assay for three scrapie positive and three scrapie negative samples.
96 G. Hayward et al. / Sensing and Bio-Sensing Research 11 (2016) 94–98To isolate the shoulder response, an ‘osculating’ ﬁrst order decay
curve was matched to the data at three points as shown in Fig. 3. The
purpose of this osculating curve is to provide a baseline to subtract
from the raw frequency shift data. This subtraction leads to a frequency
difference curve that clearly reveals the shoulder when present.
Fig. 4 illustrates the resulting frequency difference curves. The shoul-
der manifests itself as an early (ﬁrst 2 to 3 h) and noticeable frequency
difference peak for the scrapie infected samples. The negative samples
show no signs of a distinct peak. The early frequency difference for the
negative samples is noisy but the difference remains considerably less
than about 50 Hz for negative samples.
The noise evident in Fig. 4 suggests that a diagnostic threshold of the
order of 50 Hz prevails. In further trials, 45 scrapie and 45 normal sam-
pleswere tested and diagnosed by the acoustic prion sensor through the
presence of a peak. The diagnoses were conﬁrmed by both ELISA and
immuno-histochemical examination as stated in the materials and
methods section. No false negatives and 5 false positive resultswere ob-
tained [10]. Thus, the TSM is capable of distinguishing between positive
and negative scrapie brain samples.Fig. 3. Osculating ﬁt of ﬁrst order decay curve to a representative scrapie positive sample
frequency response of the acoustic prion sensor.3.2. Proposed sensing mechanism
The second objective of this paper is to explore the premise that the
mechanism of the TSM aligns with important elements of prion disease
propagation mechanism. The proposed mechanism for the TSM re-
sponse is a combination of non-speciﬁc binding to the sensor surface,
speciﬁc prion and cell debris binding and a change in the hydrophobic-
ity of the surface that is potentially linked to the conformational shift of
the sensor bound recombinant PrPC. The frequency response impact of
these three individual interactions is captured in Fig. 5 as an illustrative
model. The non-speciﬁc and speciﬁc bindings are both represented as
ﬁrst order decreases in the frequency. The increasedmass on the surface
combined with the increased viscosity of the surface layer lead to the
frequency reduction as widely seen with TSMs [4,5]. The ﬁrst order
shape is based on simple mass transfer rates. The increased hydropho-
bicity of the surface leads to an increase in frequency, which would be
expected if the surface PrPC undergoes a conformational shift. The sig-
moidal curve represents a simple model for this type of process.
Fig. 6 illustrates the ability of the conceptual model tomatch the ob-
served frequency shifts for both negative samples and positive samples.
The modeled results within Fig. 6 are not predictive. The alignment ofFig. 5. Three proposed components of the acoustic prion assay frequency responsemodel.
Fig. 6. Combined conceptual model applied to scrapie positive and scrapie negative
frequency response curves produced by the acoustic prion assay.
Fig. 7. Positive chronic wasting disease observed via frequency response of the acoustic
prion assay.
Fig. 8. Decrease in the acoustic prion assay signal by addition and incubation of blood
plasma with scrapie positive brain homogenate samples.
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TSM response mechanism.
Returning to Fig. 4, the two-hour time frame of the peak is consistent
with the acquisition of detergent insolubility observed by Lehmann and
Harris [11]. In other words, the two-hour time frame is consistent with
the observed conformational shift kinetics that have been seen in other
settings.
Prion infection acquired through the gutﬁrst reaches the lower brain
[12], thus, the obex sample may be expected to containmore PrPSc than
the samples from higher in the brain [13]. Fig. 4 shows a markedly
higher frequency response for the obex sample which would be consis-
tent with a higher concentration of PrPSc.
It is known that it is possible to transmit this disease between spe-
cies. In a set of preliminary trials, CWD (Chronic Wasting Disease) pos-
itive elk brain samples were used to explore the acoustic prion sensor's
response between species. CWD is a prion disease affecting a number of
cervid species including elk and some deer. For this trial of the assay, elk
brain samples were prepared in a manner similar to the preparation of
the scrapie samples and were conﬁrmed positive by ELISA. The proce-
dure for testing these samples was the same as that used for the scrapie
samples and the same recombinant sheep PrPC coating layer was used.
The results shown in Fig. 7 still show a characteristic peak although
the sensing layer was the recombinant sheep PrPC rather than an elk
PrPC, as would be more appropriate. The peak is signiﬁcantly lower
than those obtained with sheep PrPSc (data from Fig. 4 is included for
comparison). While this reduction may be the result of differing PrPSc
concentrations, the peaks are also slower and much broader.
The transmission of CWD to sheep has been shown to be possible
[14] but not efﬁcient. In addition to the species difference, the efﬁciency
depends on polymorphisms in the Prnp gene of the receiving animal.
The lower and slower response peaks shown in Fig. 7 appear to be con-
sistent with this reduced interaction efﬁciency thus the acoustic sensor
may offer a means to study these effects.
A second set of preliminary trials was carried out where blood plas-
ma was found to decrease the acoustic signal produced by scrapie pos-
itive samples. To assess this effect, equal parts of sheep brain
homogenate positive for scrapie and sheep blood plasma from control
animals (scrapie negative) were mixed and incubated at 37 °C for a
range of incubation times. For the control, scrapie negative brain ho-
mogenate was substituted for the plasma. Following the incubation,
the mixture was applied to a sensor coated with the recombinant pro-
tein as outlined in the materials and methods section. As shown in
Fig. 8 using the shoulder extraction method, as the mixture incubationtime increased, the positive scrapie signal decreased until after 1 h of in-
cubation, it became undetectable.
Since the incubation was carried out before applying the mixture to
the coated TSM sensor, this effect is a result of an interaction between
components of the plasma and the brain samples. One example of
such an interaction is binding of plasminogen to PrPSc [15]. It is apparent
that this acoustic assay may also offer a means to study this type of
interaction.
4. Conclusion
A thickness shear resonator coated with a recombinant sheep prion
protein is capable of detecting scrapie infection in sheep brain homoge-
nate samples. The observed indication of infection is a shoulder in the
frequency response of scrapie positive samples, occurring during the
ﬁrst 2 h following sample addition on the acoustic prion sensor. This
shoulder was extracted by subtracting an ‘osculating’ decay curve. The
peaks resulting from this subtraction were clearly distinguishable
from the background noise. In 95 trials, only 5 false positive results
were obtained with no false negatives.
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produced by the assay could possibly be the result of the conversion
of α-helices in the surface protein to a more hydrophobic β-sheet con-
formation. In addition to the frequency changes associated with the di-
agnostic mechanism, the response of the TSM in terms of time and
concentration, as well as the TSM response to trials simulating cross
species and blood plasma effects, are consistent with this model and
the disease. These observations are not sufﬁcient to prove the mecha-
nism of the TSM sensor nor are they sufﬁcient to prove that the recom-
binant PrPC surface layer is refolding. However, if the mechanism of the
acoustic prion sensor is an analog of the in-vivo prion propagation
mechanism then the sensor offers not only a detection capacity but
also a potential means to explore this disease further in a rapid and in-
expensive manner.
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